200
Participants
Start Date
September 22, 2016
Primary Completion Date
December 20, 2018
Study Completion Date
December 20, 2018
Tocilizumab
Subcutaneous Tocilizumab according to approved label.
Rheumatology Private Practice, Athens
General Hospital of Athens KAT, Rheumatology, Athens
Rheumatology Private Practice, Kalithea, Athens
Rheumatology Private Practice, Eleusina
Rheumatology Private Practice, Pátrai
Olympion Medical Center of Patras, Internal Medicine Clinic, Pátrai
Rheumatology Private Practice, Volos
Rheumatology Private Practice, Thessaloniki
Rheumatology Private Practice, Véroia
Rheumatology Private Practice, Serres
General Hospital of Kavala; Rheumatology, Kavala
Private Practice Rheumatology, Papadimitriou, Drama
Private Practice Rheumatology, Merantzis, Agrinio
Rheumatology Private Practice, Athens
Private Practice Rheumatology, Stavropoulos, Áno Patísia
Rheumatology Private Practice, Kifissia
General Hospital Agios Pavlos, Thessaloniki
Rheumatology Private Practice, Thessaloniki
Rheumatology Private Practice, Chania
ATTIKO Hospital_4th University Internal Medicine Clinic, Haidari
Private Practice Rheumatology, Georgiadis, Ioannina
Private Practice Rheumatology, Kotrotsios, Karditsa
Private Practice Rehumatology, Ziogas, Larissa
General Hospital of Mytilini, Rheumatology, Mytilene
Private Practice Rheumatology, Trontzas, Néa Smýrni
Private Practice Rheumatology, Psaltis, Serres
Hoffmann-La Roche
INDUSTRY